These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 21803086)

  • 21. Prognostic impact of types of atrial fibrillation in acute coronary syndromes.
    Lau DH; Huynh LT; Chew DP; Astley CM; Soman A; Sanders P
    Am J Cardiol; 2009 Nov; 104(10):1317-23. PubMed ID: 19892044
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic value of troponins in acute pulmonary embolism: a meta-analysis.
    Becattini C; Vedovati MC; Agnelli G
    Circulation; 2007 Jul; 116(4):427-33. PubMed ID: 17606843
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coronary stenting is associated with an acute increase in plasma myeloperoxidase in stable angina patients but not in patients with acute myocardial infarction.
    Aminian A; Boudjeltia KZ; Babar S; Van Antwerpen P; Lefebvre P; Crasset V; Leone A; Ducobu J; Friart A; Vanhaeverbeek M
    Eur J Intern Med; 2009 Sep; 20(5):527-32. PubMed ID: 19712859
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Necrotic core and its ratio to dense calcium are predictors of high-risk non-ST-elevation acute coronary syndrome.
    Missel E; Mintz GS; Carlier SG; Sano K; Qian J; Kaple RK; Castellanos C; Dangas G; Mehran R; Moses JW; Stone GW; Leon MB
    Am J Cardiol; 2008 Mar; 101(5):573-8. PubMed ID: 18308001
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognosis of patients suffering an acute coronary syndrome while already under chronic clopidogrel therapy.
    Bonello L; De Labriolle A; Lemesle G; Steinberg DH; Roy P; Torguson R; Suddath WO; Satler LF; Kent KM; Pichard AD; Waksman R
    Catheter Cardiovasc Interv; 2009 Jun; 73(7):866-70. PubMed ID: 19198009
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of myeloperoxidase as predictor of systemic inflammatory response syndrome in patients with ST-segment elevation myocardial infarction after primary percutaneous coronary intervention.
    Samimi-Fard S; Dominguez-Rodriguez A; Abreu-Gonzalez P; Enjuanes-Grau C; Blanco-Palacios G; Hernandez-Baldomero IF; Bosa-Ojeda F; Marrero-Rodríguez F
    Am J Cardiol; 2009 Sep; 104(5):634-7. PubMed ID: 19699336
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term outcome of patients of over 85 years old with acute coronary syndrome undergoing percutaneous coronary stenting: a comparison of bare metal stent and drug eluting stent.
    Ma HY; Zhou YJ; Dick RJ; Shi DM; Liu YY; Cheng WJ; Guo YH; Wang JL; Ge HL
    Chin Med J (Engl); 2008 May; 121(10):887-91. PubMed ID: 18706201
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Short- and long-term outcomes following atrial fibrillation in patients with acute coronary syndromes with or without ST-segment elevation.
    Lopes RD; Pieper KS; Horton JR; Al-Khatib SM; Newby LK; Mehta RH; Van de Werf F; Armstrong PW; Mahaffey KW; Harrington RA; Ohman EM; White HD; Wallentin L; Granger CB
    Heart; 2008 Jul; 94(7):867-73. PubMed ID: 18332062
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serial bedside B-type natriuretic peptide strongly predicts prognosis in acute coronary syndrome independent of echocardiographic abnormalities.
    Ang DS; Kong CF; Kao MP; Struthers AD
    Am Heart J; 2009 Jul; 158(1):133-40. PubMed ID: 19540403
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Additive prognostic value of NT-proBNP over TIMI risk score in intermediate-risk patients with acute coronary syndrome.
    Eren NK; Ertaş F; Yüksek U; Cakir C; Nazli C; Köseoğlu M; Ergene O
    Turk Kardiyol Dern Ars; 2009 Jan; 37(1):1-8. PubMed ID: 19225247
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elevated serum myeloperoxidase activities are significantly associated with the prevalence of ACS and High LDL-C levels in CHD patients.
    Liu C; Xie G; Huang W; Yang Y; Li P; Tu Z
    J Atheroscler Thromb; 2012; 19(5):435-43. PubMed ID: 22659527
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Meta-analysis of randomized trials of glycoprotein IIb/IIIa inhibitors in high-risk acute coronary syndromes patients undergoing invasive strategy.
    De Luca G; Navarese EP; Cassetti E; Verdoia M; Suryapranata H
    Am J Cardiol; 2011 Jan; 107(2):198-203. PubMed ID: 21211597
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic value of admission myeloperoxidase levels in patients with ST-segment elevation myocardial infarction and cardiogenic shock.
    Dominguez-Rodriguez A; Samimi-Fard S; Abreu-Gonzalez P; Garcia-Gonzalez MJ; Kaski JC
    Am J Cardiol; 2008 Jun; 101(11):1537-40. PubMed ID: 18489929
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Emergency physician high pretest probability for acute coronary syndrome correlates with adverse cardiovascular outcomes.
    Chandra A; Lindsell CJ; Limkakeng A; Diercks DB; Hoekstra JW; Hollander JE; Kirk JD; Peacock WF; Gibler WB; Pollack CV;
    Acad Emerg Med; 2009 Aug; 16(8):740-8. PubMed ID: 19673712
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A myeloperoxidase promoter polymorphism is independently associated with mortality in patients with impaired left ventricular function.
    Rudolph V; Rudolph TK; Kubala L; Clauberg N; Maas R; Pekarova M; Klinke A; Lau D; Szöcs K; Meinertz T; Böger RH; Baldus S
    Free Radic Biol Med; 2009 Dec; 47(11):1584-90. PubMed ID: 19735726
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Prognostic value of first fasting glucose measurement compared with admission glucose level in patients with acute coronary syndrome].
    Vivas D; García-Rubira JC; González-Ferrer JJ; Núñez-Gil I; del Prado N; Fernández-Ortiz A; Macaya C
    Rev Esp Cardiol; 2008 May; 61(5):458-64. PubMed ID: 18462648
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical outcome after acute coronary syndrome in Japanese patients: an observational cohort study.
    Nakamura M; Yamashita T; Yajima J; Oikawa Y; Ogasawara K; Sagara K; Kirigaya H; Koike A; Nagashima K; Ohtsuka T; Uejima T; Suzuki S; Sawada H; Aizawa T
    J Cardiol; 2010 Jan; 55(1):69-76. PubMed ID: 20122551
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High levels of systemic myeloperoxidase are associated with coronary plaque erosion in patients with acute coronary syndromes: a clinicopathological study.
    Ferrante G; Nakano M; Prati F; Niccoli G; Mallus MT; Ramazzotti V; Montone RA; Kolodgie FD; Virmani R; Crea F
    Circulation; 2010 Dec; 122(24):2505-13. PubMed ID: 21126969
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term outcome of a routine versus selective invasive strategy in patients with non-ST-segment elevation acute coronary syndrome a meta-analysis of individual patient data.
    Fox KA; Clayton TC; Damman P; Pocock SJ; de Winter RJ; Tijssen JG; Lagerqvist B; Wallentin L;
    J Am Coll Cardiol; 2010 Jun; 55(22):2435-45. PubMed ID: 20359842
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic significance of preprocedural troponin-I in patients with non-ST elevation acute coronary syndromes undergoing percutaneous coronary intervention.
    Napan S; Kashinath RC; Kadri S; Orig MN; Khadra S
    Coron Artery Dis; 2010 Aug; 21(5):261-5. PubMed ID: 20555264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.